Cargando…
Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells
Cancer stem cells, also termed tumor initiating cells (TICs), are a rare population of cells within the tumor mass which initiate tumor growth and metastasis. In pancreatic cancer, TICs significantly contribute to tumor re-growth after therapy, due to their intrinsic resistance. Here we demonstrate...
Autores principales: | Benguigui, Madeleine, Weitz, Iris S., Timaner, Michael, Kan, Tal, Shechter, Dvir, Perlman, Or, Sivan, Sarit, Raviv, Ziv, Azhari, Haim, Shaked, Yuval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717199/ https://www.ncbi.nlm.nih.gov/pubmed/31471546 http://dx.doi.org/10.1038/s41598-019-48959-8 |
Ejemplares similares
-
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
por: Benguigui, Madeleine, et al.
Publicado: (2017) -
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors
por: Vorontsova, Avital, et al.
Publicado: (2023) -
Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1
por: Timaner, Michael, et al.
Publicado: (2019) -
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors
por: Benguigui, Madeleine, et al.
Publicado: (2022) -
The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment
por: Vorontsova, Avital, et al.
Publicado: (2020)